Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay for Modern Biomedical Research

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes a water-soluble WST-8 tetrazolium salt to enable rapid and quantitative measurement of cell viability and proliferation in vitro (ApexBio). Its mechanism directly reflects mitochondrial dehydrogenase activity, providing a more sensitive and convenient alternative to MTT and XTT assays (Houston Biochem). CCK-8 is widely adopted in cancer and neurodegenerative disease studies for high-throughput quantification of cytotoxicity and proliferation (Xie et al., 2025). The water-soluble formazan product improves workflow integration and reduces assay variability. Its precision and reproducibility have made it a gold standard across biomedical research workflows.

Biological Rationale

Cell viability and proliferation are fundamental parameters for understanding physiological and pathological processes. Quantitative assessment of viable cells is required in cancer biology, toxicology, regenerative medicine, and drug development (Xie et al., 2025). Most viability assays rely on metabolic activity, which correlates strongly with cell number under defined conditions. CCK-8 leverages the activity of mitochondrial dehydrogenases, abundant in living cells, to convert WST-8 to a water-soluble formazan dye. The amount of dye generated is proportional to the viable cell count. This approach is advantageous because it is non-radioactive, does not require cell lysis, and is suitable for high-throughput formats.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 contains the WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) reagent. Viable cells with active mitochondrial dehydrogenases enzymatically reduce WST-8 to a yellow-orange formazan product. This reduction is facilitated by NADH or NADPH electron donors within the mitochondrial respiratory chain. The formazan product is fully water-soluble, allowing direct quantification via absorbance measurement at 450 nm in a standard microplate reader (ApexBio).

• The reaction does not require washing or solubilization steps, reducing assay time and error.
• The amount of formazan formed is directly proportional to the number of viable (metabolically active) cells per well.
• Unlike MTT or XTT, no organic solvents are needed to dissolve the dye, minimizing cytotoxicity and improving compatibility with downstream applications (Colorimetric Assay).

Evidence & Benchmarks

• CCK-8 demonstrates a linear correlation (R² > 0.99) between absorbance at 450 nm and viable cell number (10²–10⁵ cells/well in 96-well plates) under standard culture conditions (37°C, 5% CO₂, 2–4 h incubation) (ApexBio).
• Detection sensitivity surpasses MTT and XTT, with lower limits of detection at fewer than 100 cells/well (Houston Biochem).
• In cancer research, CCK-8 is used to assess drug-induced cytotoxicity and proliferation, as recently applied to study extrachromosomal DNA (ecDNA) dynamics in mitotic segregation and therapy resistance (Xie et al., 2025).
• Assay readouts are reproducible with intra-assay CV < 10% and inter-assay CV < 15% when performed according to manufacturer protocol (ApexBio).
• Compatibility with a wide range of mammalian and primary cell types, including adherent and suspension cultures, has been demonstrated (CA-074.com).

Applications, Limits & Misconceptions

CCK-8 is widely applied in:

• Cancer cell proliferation and cytotoxicity screening.
• Assessment of neurodegenerative disease models (e.g., neuronal viability after oxidative insult).
• Drug screening for anti-cancer and neuroprotective compounds.
• Cellular metabolic activity and mitochondrial function assays.
• Regenerative medicine and stem cell viability studies.

This article extends advanced insights into WST-8-based assays by providing updated quantitative benchmarks and new cancer research use cases, such as ecDNA segregation studies. See also applications in oxidative stress and mitochondrial activity, which this article clarifies by detailing CCK-8’s specificity for dehydrogenase-based viability measurement.

Common Pitfalls or Misconceptions

• CCK-8 does not directly measure apoptosis or necrosis; it quantifies viable/metabolically active cells only.
• Highly confluent or overgrown cultures may result in substrate depletion and non-linear readouts.
• Compounds that interfere with mitochondrial function (e.g., electron transport chain inhibitors) can confound results by reducing formazan formation independent of cell number.
• CCK-8 is not validated for use with non-mammalian or microbial cells without additional optimization.
• The assay readout may be affected by colored compounds or media components absorbing at 450 nm.

Workflow Integration & Parameters

• Seed cells in 96- or 384-well plates at densities ranging from 1 × 10² to 1 × 10⁵ cells/well.
• Allow cells to adhere (for adherent lines) and recover for 12–24 hours in appropriate growth media.
• Add 10 μL CCK-8 solution per 100 μL culture medium per well.
• Incubate at 37°C, 5% CO₂ for 1–4 hours; optimal time depends on cell type and density.
• Measure absorbance at 450 nm using a microplate reader (Cell Counting Kit-8 (CCK-8)).

The water-soluble nature of formazan enables direct downstream assays or imaging. For troubleshooting and advanced workflow optimization, see this guide on robust results, which this article updates by including recent cancer-specific benchmarks.

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) offers a sensitive, robust, and user-friendly platform for cell viability and cytotoxicity measurement. Its water-soluble WST-8 substrate and direct colorimetric readout streamline experimental workflows and enhance reproducibility. CCK-8 has become a foundational tool in cancer research, neurodegenerative disease modeling, and drug discovery, as highlighted by its role in studies of ecDNA segregation and therapy resistance (Xie et al., 2025). Future developments may further expand its use for kinetic metabolic profiling and combination with multiplexed assays.